Volume 39, Number 12, 2595-2600, DOI: 10.1007/BF02087695

Published in partnership with the

Logo

Gastroenterology Research Group

Oral bacteriotherapy for viral gastroenteritis

Erika Isolauri, Minna Kaila, Hannu Mykkänen, Wen Hua Ling and Seppo Salminen

View Related Documents

Abstract

The effect of orally administered lactobacilli on acute rotavirus diarrhea was tested in 42 well-nourished children ages 5–28 months. After oral rehydration, the patients were randomized to a study group, receiving humanLactobacillus casei strain GG 1010 colony-forming units twice daily for five days, or a control group not given lactobacilli.Lactobacillus GG was found in the feces in 83% of the study group. The diarrheal phase was shortened in that group. Dietary supplementation with lactobacilli significantly influenced the bacterial enzyme profile: urease activity during diarrhea transiently increased in the control group but not in the study group;F=8.6,P=0.01. No intergroup differences were found in beta-glucuronidase, beta-glucosidase, and glycocholic acid hydrolase levels. We suggest that rotavirus infection gives rise to biphasic diarrhea, the first phase being an osmotic diarrhea and the second associated with overgrowth of specifically urease-producing bacteria. Oral bacteriotherapy appears a promising means to counteract the disturbed microbial balance.

Key words  infantile diarrhea - rotavirus infections -  Lactobacillus casei  - clinical

This study was supported by the Academy of Finland and the Foundation for Nutrition Research (Finland).

Fulltext Preview

Image of the first page of the fulltext document